TOPIC CENTER

818 Articles

Updated Oct 6, 2026

Articles

Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.

M&A
Activist Investors Eyeing Big Pharma: What It Means for the Industry
4 min read • 2 years ago
News
Afton Scientific to Invest $200 Million on Facility Expansion
4 min read • 2 years ago
Funding & Investments
Matica Secures Multiple Viral Vector CDMO Contracts
4 min read • 2 years ago
Regulatory & Compliance
Zealand Pharma Faces Second FDA Rejection Due to CDMO Inspection Issues
4 min read • 2 years ago
Manufacturing Services
SpectronRx Announces Collaboration for European Radiotherapy Isotope Manufacturing Facility
4 min read • 2 years ago
M&A
AGC Pauses CGT Operations
4 min read • 2 years ago
M&A
Celltrion to Establish Wholly-Owned CDMO Subsidiary by End of 2024
4 min read • 2 years ago
News
OmniaBio Opens New Facility in Canada to Advance Cell and Gene Therapy Manufacturing
4 min read • 2 years ago
M&A
Evonik Announces 260 More Layoffs as Part of Multi-Year Restructuring
4 min read • 2 years ago
Manufacturing Services
Sanofi and Orano Partner to Develop Next-Generation Radioligand Cancer Therapies
4 min read • 2 years ago
News
Catalent Expands ASD Capabilities in Boston
4 min read • 2 years ago
Manufacturing Services
LaNova Medicines Secures $42 Million in Funding to Accelerate Oncology Innovations
4 min read • 2 years ago

‹
1
…
42
43
44
…
69
›

Stay Ahead in Pharma Intelligence

Join industry executives receiving our market briefings.